Rituximab is highly effective for pure red cell aplasia and post-transplant lymphoproliferative disorder after unrelated hematopoietic stem cell transplantation

Pure red cell aplasia (PRCA) and post-transplant lymphoproliferative disorder (PTLD) constitute rare complications after allogeneic hematopoietic stem cell transplantation (AlloHSCT). The incidence of EBV-PTLD is above 1%, but it may increase in patients with well-known risk factors such as EBV sero...

Descripción completa

Detalles Bibliográficos
Autores principales: Kopińska, Anna, Helbig, Grzegorz, Frankiewicz, Andrzej, Grygoruk-Wiśniowska, Iwona, Kyrcz-Krzemień, Sławomira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687412/
https://www.ncbi.nlm.nih.gov/pubmed/23788882
http://dx.doi.org/10.5114/wo.2012.29287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687412/
https://www.ncbi.nlm.nih.gov/pubmed/23788882
http://dx.doi.org/10.5114/wo.2012.29287

Ejemplares similares